The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

We have made great strides in the medical community, with people having access to life-saving physical drugs as well as mental health medicine. A recent approval made by the FDA could be a great step for people who could not find respite with prior approved depression drugs.